Seeing Is Believing
DCPH is currently covered by 7 analysts with an average potential upside of $15.01 (45.4%) from yesterday's end of day stock price of $12.94. Deciphera Pharmaceuticals activity chart has currently 58 price targets and 72 ratings on display.
Analysts average stock forecasts to be materialized ratio is 43.87% with an average time for these price targets to be met of 134.93 days.
Highest price target for DCPH is $22, Lowest price target is $8, average price target is $15.
Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 31-Oct-2023. First documented stock forecast 04-Jun-2018.
Currently, out of the existing stock ratings of DCPH - 5 which are a Hold (27.78%), 11 which are a Buy (61.11%), 2 which are a Sell (11.11%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
22
$9.06 (70.02%)
14
1 months 3 days ago
1/3 (33.33%)
$12.36 (55.74%)
11
Hold
1 months 3 days ago
0/3 (0%)
$30.39 (62.41%)
Hold
23
$10.06 (77.74%)
13
1 months 4 days ago
10/18 (55.56%)
$14.54 (46.65%)
237
Buy
25
$12.28 (96.54%)
25
3 months 24 days ago
3/8 (37.5%)
$13.97 (72.54%)
118
Buy
23
$10.06 (77.74%)
23
5 months 29 days ago
1/6 (16.67%)
$5.64 (26.73%)
34
What is DCPH (Deciphera Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on DCPH (Deciphera Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on DCPH (Deciphera Pharmaceuticals)?
Which analyst is the currently most bullish on DCPH (Deciphera Pharmaceuticals)?
Which analyst is the currently most reserved on DCPH (Deciphera Pharmaceuticals)?